Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,785 | -9,467 | -7,371 | -5,154 | -3,127 |
| Depreciation Amortization | 133 | 744 | 583 | 392 | 196 |
| Accounts payable and accrued liabilities | 22 | 184 | 70 | 22 | 253 |
| Other Working Capital | 8 | 21 | -160 | -136 | 276 |
| Other Operating Activity | 28 | 40 | 102 | 91 | -193 |
| Operating Cash Flow | $-1,594 | $-8,479 | $-6,777 | $-4,786 | $-2,595 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -84 | -57 | -47 | -47 | -47 |
| Investing Cash Flow | $-84 | $-57 | $-47 | $-47 | $-47 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,245 | 5,296 | 4,568 | 3,993 | 1,710 |
| Financing Cash Flow | $1,245 | $5,296 | $4,568 | $3,993 | $1,710 |
| Beginning Cash Position | 1,559 | 4,798 | 4,798 | 4,798 | 4,798 |
| End Cash Position | 1,126 | 1,559 | 2,543 | 3,958 | 3,866 |
| Net Cash Flow | $-433 | $-3,239 | $-2,255 | $-840 | $-932 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,594 | -8,479 | -6,777 | -4,786 | -2,595 |
| Capital Expenditure | -84 | -57 | -47 | -47 | -47 |
| Free Cash Flow | -1,678 | -8,536 | -6,824 | -4,833 | -2,642 |